Optinose Announces Reporting Date for First Quarter 2021 Financial Results and Upcoming Healthcare Conference Presentation Apr 28, 2021 08:30AM
Optinose to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference May 14, 2020 04:15PM
Optinose Reports First Quarter 2019 Financial Results and Recent Operational Highlights May 9, 2019 07:00AM
Optinose Reports First Quarter 2019 Financial Results and Recent Operational Highlights May 9, 2019 07:00AM
Optinose (OPTN) PT Lowered to $25 at RBC Capital, Remains Bullish Mar 7, 2019 06:32AM


Jun 11, 2018 04:25PM Optinose Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Common Shares
Jun 11, 2018 04:25PM Optinose Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Common Shares
Jun 7, 2018 05:59AM OptiNose (OPTN) Prices 5 Million Common Shares at $22.25 Per Share
Jun 6, 2018 08:21PM Optinose Announces Pricing of Public Offering of Common Stock
Jun 6, 2018 08:21PM Optinose Announces Pricing of Public Offering of Common Stock
Jun 4, 2018 04:57PM OptiNose (OPTN) Commences 4.5M Share Offering of Common Stock
Jun 4, 2018 04:56PM Optinose Announces Launch of Public Offering of Common Stock
Jun 4, 2018 04:56PM Optinose Announces Launch of Public Offering of Common Stock
Feb 15, 2018 08:00AM Optinose to Present at the 2018 RBC Capital Markets Healthcare Conference
Feb 15, 2018 08:00AM Optinose to Present at the 2018 RBC Capital Markets Healthcare Conference
Nov 7, 2017 04:36AM RBC Capital Starts Optinose (OPTN) at Outperform
Oct 17, 2017 04:01PM Optinose Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
Oct 13, 2017 11:05AM OptiNose (OPTN) IPO Opens Higher